Novozymes to Buy EMD/Merck Crop BioScience

21.12.2010 - Novozymes, the world's top industrial enzymes maker, is buying U.S. based EMD/Merck Crop BioScience for $275 million from Merck KGaA , boosting its presence in the fast-growing...